These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 11399948)

  • 21. Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques.
    Devys A; Thedrez P; Gautherot E; Faivre-Chauvet A; Saï-Maurel C; Rouvier E; Auget JL; Barbet J; Chatal JF
    Int J Cancer; 1996 Sep; 67(6):883-91. PubMed ID: 8824563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of murine placental degradation and transfer of [125I]iodo-epidermal growth factor.
    DiAugustine RP; Rosch MJ; Lannon DE; Walker MP; Pratt RM
    Endocrinology; 1987 Mar; 120(3):1190-200. PubMed ID: 3492368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
    Ryan PD; Hilf R
    Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
    Stromberg K; Hudgins WR
    Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
    Weber W; Weber J; Senekowitsch-Schmidtke R
    Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor promoter-induced inhibition of epidermal growth factor binding to cultured mouse primary epidermal cells.
    Lockyer JM; Bowden GT; Matrisian LM; Magun BE
    Cancer Res; 1981 Jun; 41(6):2308-14. PubMed ID: 6972249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular modification of 125I-labeled epidermal growth factor by normal human foreskin fibroblasts.
    Schaudies RP; Savage CR
    Endocrinology; 1986 Feb; 118(2):875-82. PubMed ID: 2867893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular processing of 125I-epidermal growth factor in rat embryo fibroblasts.
    Magun BE; Planck SR; Wagner HN
    J Cell Biochem; 1982; 20(3):259-76. PubMed ID: 6984857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor binding sites in the mouse exocrine and endocrine pancreas shown by in vivo quantitative microautoradiography and confocal laser scanning microscopy.
    Watanabe M; Jo N; Nishimura Y; Takafuchi M; Kuno M; Kanbara K; Kiyokane K; Shimada M
    Acta Histochem; 1997 Mar; 99(1):55-62. PubMed ID: 9150797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid-mediated alteration in growth factor binding and action: analysis of the binding change.
    Baker JB; Cunningham DD
    J Supramol Struct; 1978; 9(1):69-77. PubMed ID: 215839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of osteosarcoma EGF receptor affinity by phorbol ester and cyclic AMP.
    Borst SE; Catherwood BD
    J Bone Miner Res; 1989 Apr; 4(2):185-91. PubMed ID: 2471395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport of 125I-EGF into milk and effect of sialoadenectomy on milk EGF in mice.
    Gresik EW; van der Noen H; Barka T
    Am J Physiol; 1984 Sep; 247(3 Pt 1):E349-54. PubMed ID: 6332542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chloroquine allows the secretion of internalized 125I-epidermal growth factor from fibroblasts.
    Wakshull E; Cooper JL; Wharton W
    J Cell Physiol; 1985 Nov; 125(2):215-22. PubMed ID: 3877059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.
    Tysnes BB; Haugland HK; Bjerkvig R
    Invasion Metastasis; 1997; 17(5):270-80. PubMed ID: 9876221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity of ligand and antibody-directed ricin A-chain conjugates recognizing the epidermal growth factor receptor.
    Vollmar AM; Banker DE; Mendelsohn J; Herschman HR
    J Cell Physiol; 1987 Jun; 131(3):418-25. PubMed ID: 3496342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [125I]iodo-epidermal growth factor binding and mitotic responsiveness of porcine granulosa cells are modulated by differentiation and follicle-stimulating hormone.
    Buck PA; Schomberg DW
    Endocrinology; 1988 Jan; 122(1):28-33. PubMed ID: 3121283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of epidermal growth factor (EGF) receptor activity during the modulation of protein synthesis.
    Carpenter G
    J Cell Physiol; 1979 Apr; 99(1):101-6. PubMed ID: 222774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of oxidative iodination of epidermal growth factor on its binding and secretion by hepatocytes.
    Marti U; Burwen SJ; Barker ME; Huling S; Feren AM; Jones AL
    J Cell Biochem; 1989 May; 40(1):109-19. PubMed ID: 2787328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The intracellular degradation of 125I-EGF and the release of low-molecular degradation products under conditions of actin cytoskeleton disorganization].
    Barkan RS; Alekseev VIu
    Tsitologiia; 1993; 35(4):73-80. PubMed ID: 8328027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding, internalization, and degradation of epidermal growth factor by balb 3T3 and BP3T3 cells: relationship to cell density and the stimulation of cell proliferation.
    Brown KD; Yeh YC; Holley RW
    J Cell Physiol; 1979 Aug; 100(2):227-38. PubMed ID: 315945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.